Pharmaceutical Investing Neon Therapeutics Completes Enrollment in Phase 1b NT-002 Clinical Trial for Metastatic Non-Small Cell Lung Cancer
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery